Arkolith/Insider Trading/FREQ/Form 4

Loose Christopher R.

Chief Scientific OfficerFrequency Therapeutics, Inc. (FREQ) · full profile →Form 4 · filed Jul 17, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1K
Net Open-Market Flow
-$1K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 14, 2023Sell(S)906$0.59$535197K
Jul 13, 2023Sell(S)1K$0.39$518198K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-23-020819) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML